• Hidenori Kamiyama, Kimiko Kurosawa, Terumasa Ozawa, Keiko Kobayashi, Kenji Gonda, Masatoshi Teshigawara, Akiko Sato, Ken-Ichi Maekawa, and Motohiro Matoba.
• Palliative Care Team and Department of Surgery, Chichibu Municipal Hospital, Chichibu, Saitama, Japan. kamiyama@omiya.jichi.ac.jp.
• J Community Support Oncol. 2015 Nov 1; 13 (11): 405-10.

BackgroundIt is important to know when to decide to end palliative chemotherapy (PC) for the quality of life of patients. However, there is currently no clear agreement on when to terminate PC.ObjectivesTo determine whether the difference of the period between the completion of PC and death affects patients' trajectory of supportive care near end of life.MethodsThis retrospective study included 52 adult patients with incurable cancer who had received PC and who were referred to our palliative care team and died in our local hospital between July 2011 and June 2014. Group A comprised patients who received anticancer therapy such as surgery and PC only in our hospital and eventually died there. Group B comprised patients who were transitioned to our hospital from tertiary medical centers after cessation of PC.Results17 of 22 patients (77%) in Group A conveyed the intention of continuing PC in the first interview with a physician of the palliative care team, whereas 4 of 30 patients (13%) in Group B conveyed a similar intention. The patients in Group B stopped PC a median of 43 days earlier than did the patients in Group A (𝑃 < .0001).ConclusionsThese data showed that more patients in Group A wanted to continue PC and had a shorter interval between last PC and death. Change in the hospital where the patients are given supportive care might contribute to the cessation of futile PC at an appropriate time.©2015 Frontline Medical Communications.

0 keywords...

hide…